Skip to Main Content
An official website of the United States government
CDAS has a New Look: On December 9th, the CDAS website was updated with a new design! The update incorporates all of the existing CDAS functionality with a more modern and user friendly interface.

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
781-800 of 2612
Name Principal Investigator Institution Study Date Approved Project ID
BMI and the risk of renal cell carcinoma : a case control study Benjamin Chung Stanford University PLCO Jan 18, 2022 PLCO-896
Radiomic analysis of Chest radiographs for prediction of lung cancer outcomes Anant Madabhushi Emory University PLCO Jan 18, 2022 PLCOI-887
Interpretable AI prediction of prostate tumor staging Matthias Weidemüller Universität Heidelberg PLCO Jan 18, 2022 PLCO-897
Pulmonary Adenocarcinoma of Low Malignant Potential Eric Burks Boston University School Of Medicine NLST Jan 7, 2022 NLST-867
Threshold quantile regression models with applications to PSA data Eun Ryung Lee Sungkyunkwan University PLCO Jan 7, 2022 PLCO-893
The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with colon cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. Percy Guzman Percy Guzman PLCO Jan 7, 2022 PLCO-882
Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO Summer Han Stanford University PLCO Jan 5, 2022 PLCO-886
Development of deep learning frameworks based on pathology images for biomarker development Jennifer Beane Trustees of Boston University PLCO Jan 5, 2022 PLCOI-881
The impact of hormone replacement therapy on cancer Zhaoyu Li University of Western Australia PLCO Dec 30, 2021 PLCO-883
Meta-analysis of 16S head and neck cancer Kenny Yeo University of Adelaide PLCO Dec 14, 2021 PLCO-879
Detection of prostate cancer using machine learning techniques: An exploratory study Laxmi Manasa Gorugantu Dakota State University PLCO Dec 13, 2021 PLCO-873
Reproducibility and external validation of epidemiological risk models for endometrial cancer Aline Talhouk Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada PLCO Dec 13, 2021 PLCO-878
Breast cancer prognosis Lee Cooper Northwestern University PLCO Dec 13, 2021 PLCOI-877
Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification Eric Li Northwestern University Feinberg School of Medicine PLCO Dec 10, 2021 PLCOI-876
Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO Hormuzd Katki NCI PLCO Dec 8, 2021 PLCO-875
Using PRS for CRC screening Ulrike Peters Fred Hutchinson Cancer Research Center PLCO Dec 8, 2021 PLCO-872
Instrumental Variable Estimation of Complier Causal Treatment Effect with Interval-Censored Data Jianguo Sun University of Missouri-Columbia PLCO Nov 30, 2021 PLCO-871
Identifying risk factors for colorectal neoplasia through machine learning Daniella Araujo Universidade Federal de Minas Gerais PLCO Nov 30, 2021 PLCO-870
Melanoma Comorbidity Clusters Vishnutheertha Kulkarni Johns Hopkins University PLCO Nov 30, 2021 PLCO-869
Lower level of education matters when it comes to compliance to lung cancer screening Akeel Alali King Abdullah International Medical Research Center’s (KAIMRC) and King Saud bin Abdulaziz university for health sciences NLST Nov 30, 2021 NLST-856